Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, October 01, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
A New Solid-State Platform for High-Throughput ChIP
Thursday, September 25, 2014
Porvair’s new technical article provides an introduction to Chromatrap® 96.

Easy and Cost-Effective Generation of siRNAs from Full-Length Target Genes
Wednesday, September 24, 2014
Dicer siRNA generation kit from AMSBIO.

RAININ's New LR Low Retention Pipette Tips
Tuesday, September 23, 2014
New tips will improve users pipetting accuracy.

Fluidigm’s New Juno™ System Shatters Barriers for SNP Genotyping
Friday, September 19, 2014
New system provides simple workflow, requires minimal amount of sample input and hands-on time.

Tecan Offers NGS Sample Preparation at the Touch of a Button
Friday, September 19, 2014
Tecan’s Freedom EVO NGS workstation to offer robust and reliable automation.

Respected Synthetic Biology Group Chooses G:BOXChemi XT4
Wednesday, September 17, 2014
To speed up analysis of DNA and proteins from bacteria engineered to process heavy metals accumulated in plants grown on contaminated soil.

Complete, Automated ASTM D2983 Sample Conditioning and Testing
Tuesday, September 16, 2014
The first fully automated Thermoelectric Sample Conditioner (TESC) System from CANNON.

Rapid & Simple SPE Methods Development
Tuesday, September 16, 2014
The Development Microlute™ enables simple and rapid screening to achieve your sample preparation objectives.

Tute Genomics Launches MyGene Portal for Genome-guided Medicine
Saturday, September 13, 2014
Selected to showcase healthcare innovation at TEDMED The Hive.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 2521
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv